brentuximab vedotin (Adcetris®)
Application Details
HSE100111
26028a
brentuximab vedotin
Adcetris®
TAKEDA PRODUCTS IRELAND LTD.
09/06/2026
12/10/2023
Application Status
Full Health Technology Assessment Commissioned by HSE
23/07/2026
Rapid Review Completed
22/07/2026
Rapid Review Commissioned
10/06/2026
Pricing and Reimbursement Application Complete
09/06/2026